Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1

Journal: Nature Communications

Published: 2020-01-23

DOI: 10.1038/s41467-019-14218-7

Affiliations: 8

Authors: 23

Go to article
Institutions Share
Université Toulouse III - Paul Sabatier (UPS), France 0.28
Centre de Recherche en Cancérologie de Toulouse (CRCT), France 0.24
Ligue Contre Le Cancer - Toulouse, France 0.16
Institut Universitaire du Cancer de Toulouse-Oncopole (IUCT-Oncopole), France 0.12
Claudius Regaud Institute (ICR), France 0.09
Institute of Pharmacology and Structural Biology (IPBS), France 0.07
Mediterranean Centre for Molecular Medicine (C3M), France 0.04
Institut Fédératif de Biologie (IFB), Hôpital Purpan, France 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER